Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125552461 | 12555246 | 1 | I | 20160616 | 20160624 | 20160714 | 20160714 | PER | US-009507513-1606USA012970 | MERCK | 70.00 | YR | F | Y | 0.00000 | 20160714 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125552461 | 12555246 | 1 | PS | ZETIA | EZETIMIBE | 1 | Oral | 100 MG, UNK | 21445 | 100 | MG | TABLET | |||||||
| 125552461 | 12555246 | 2 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125552461 | 12555246 | 3 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | THYROID | U | 0 | ||||||||||
| 125552461 | 12555246 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 125552461 | 12555246 | 5 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125552461 | 12555246 | 1 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125552461 | 12555246 | Diarrhoea | |
| 125552461 | 12555246 | General physical condition abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125552461 | 12555246 | 1 | 20160609 | 0 |